O
Opus Medical
Opus Medical designs and manufactures tissue-to-bone and tissue-to tissue repair systems
About Opus Medical
Opus Medical, established in 2014, specializes in the design, production, and distribution of motion management solutions for radiation therapy and medical imaging procedures. The company's creation was the culmination of 15 years of dedicated research conducted at Stanford University and the University of Sydney, positioning it on a strong scientific foundation. Headquartered within the Cicada Innovations incubator in Sydney, Australia, all of its medical devices are manufactured locally.
The company's core business revolves around providing safe and effective tools that assist healthcare professionals during radiation treatments and diagnostic imaging. By focusing on motion management, Opus Medical addresses the critical need to minimize patient movement to ensure the accuracy and efficacy of these procedures. The business operates in the global medical device market, serving clients in the healthcare sector, specifically hospitals and clinics that offer oncology and radiology services. Revenue is generated through the sale of its proprietary medical devices. Opus Medical has secured the necessary regulatory approvals for its products, including FDA registration in the United States, CE marking for Europe, and TGA approval in Australia, allowing for clinical use in these key markets.
While specific details about the founders are not publicly available, the company emphasizes its foundation in extensive academic research, highlighting a commitment to evidence-based solutions. The leadership team fosters a diverse and collaborative environment, bringing together expertise from various fields such as research, design, manufacturing, sales, and management. This multidisciplinary approach enables the company to navigate the complexities of the medical device industry, from initial concept to commercialization and post-market support.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jun 2003 | $14M | $54M | Prospect Venture Partners | — |
| SERIES B✓Equity / VC | Jul 2002 | $6.5M | $26M | Three Arch Partners | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Opus Medical is 920 monthly website visits, up 37.3% over the last three months. Opus Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Opus Medical in the San Juan Capistrano ecosystem
The Opus Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Three Arch Partners
Series B and later1 investor entered at this stage
- PPProspect Venture Partners
Other known investors1 additional known investor
Artesian Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Opus Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Opus Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









